Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Nerve Degeneration
100%
Cell Viability
100%
Lactate Dehydrogenase
100%
Oxidopamine
100%
Dopamine Receptor Stimulating Agent
100%
Protein Disulfide Isomerase
100%
Nuclear Receptor Nur77
100%
Cytochrome C
100%
Cellular Injury
100%
Chaperonin 60
100%
Beclin 1
100%
Parkin
100%
Neuroscience
Endoplasmic Reticulum Stress
100%
In Vitro
100%
Autophagy
100%
Cell Death
100%
Cell Damage
100%
CHOP
50%
Agonist
50%
Neurodegeneration
50%
Membrane Potential
50%
Cell Viability
50%
Cytochrome C
50%
Lactate Dehydrogenase
50%
Oxidopamine
50%
Dopaminergic
50%
Parkin
50%
Nuclear Receptor Nur77
50%
Protein Disulfide-Isomerase
50%
Chaperonin 60
50%
ATF3
50%
Beclin 1
50%
Biochemistry, Genetics and Molecular Biology
Endoplasmic Reticulum Stress
100%
Autophagy
100%
Cell Death
100%
Cell Damage
100%
Downregulation
50%
Agonist
50%
Upregulation
50%
Cell Viability
50%
Lactate Dehydrogenase
50%
Dopaminergic
50%
Membrane Potential
50%
Protein Disulfide-Isomerase
50%
Nuclear Receptor Nur77
50%
PINK1
50%
ATF3
50%
HSP60
50%
Mitochondrial Disorder
50%
Cytochrome C
50%
Immunology and Microbiology
Endoplasmic Reticulum Stress
100%
Cell Death
100%
Cell Damage
100%
PC12 Cell Line
100%
Autophagy
100%
Downregulation
50%
Upregulation
50%
Agonist
50%
Cell Viability
50%
Nuclear Receptor Nur77
50%
Membrane Potential
50%
Cytosol
50%
Keyphrases
Endoplasmic Reticulum Stress (ER stress)
100%
Mitochondrial Impairment
100%
Cellular Injury
100%
PC12
100%
Nur77
100%
Apoptosis
13%
Knockdown
13%
Autophagy
13%
Cell Death
13%
6-hydroxydopamine (6-OHDA)
13%
PC12 Cells
13%
Endoplasm Reticulum Stress
13%
Reticulum
13%
Colocalization
6%
Incubation
6%
Mitochondrial Dysfunction
6%
Cell Viability
6%
Cytochrome c (Cyt c)
6%
LC3-II
6%
Intracellular Ca2+
6%
Heat Shock Protein 60 (HSP60)
6%
Mechanistic Investigation
6%
LDH Release
6%
Protein Disulfide Isomerase
6%
Tom20
6%
Mitochondrial Transmembrane Potential
6%
ROS Level
6%
Tress
6%
Parkin
6%
Cytosporone B
6%
Nuclear Orphan Receptors
6%
Dopaminergic Neurodegeneration
6%
Beclin-1
6%
PD Therapy
6%
Activating Transcription Factor 3 (ATF3)
6%